Systemic corticosteroids for the treatment of COVID-19

Affiliations

• ¹ Cochrane Haematology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Colonia, Alemania. Contibuyeron de forma igualitaria (primer autor).
• ² Department of Anaesthesiology and Intensive Care, University of Leipzig Medical Center, Leipzig, Alemania. Contibuyeron de forma igualitaria (primer autor).
• ³ Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlín, Alemania.
• ⁴ Department of Anesthesiology and Intensive Care Medicine, Campus Charité Mitte and Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlín, Alemania.
• ⁵ AWMF Institute for Medical Knowledge Management, Marburgo, Alemania.
• ⁶ Department of Anaesthesiology and Intensive Care, University of Leipzig Medical Center, Leipzig, Alemania.
• ⁷ Cochrane Metabolic and Endocrine Disorders Group, Institute of General Practice, Medical Faculty of the Heinrich-Heine-University Düsseldorf, Düsseldorf, Alemania.
• ⁸ Department of Anaesthesia and Intensive care, Universitätsklinikum Leipzig, 04103 Leipzig, Alemania.
• ⁹ Cochrane Haematology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Colonia, Alemania.
• ¹⁰ Cochrane Cancer, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Colonia, Alemania. Contibuyeron de forma igualitaria (último autor).
• ¹¹ Department of Anaesthesiology and Intensive Care, University of Leipzig Medical Center, Leipzig, Alemania. Contibuyeron de forma igualitaria (último autor).